Terms: = Colorectal cancer AND MUC16, CA125, CA-125 AND Diagnosis
116 results:
1. The value of SDC2 and Septin9 combined with serum tumor markers in early diagnosis of colorectal cancer.
Zou CS; Xie YL; Wang DX; Liu YP; Li MQ; Chen Y; Su ZL; Liu KH
Int J Colorectal Dis; 2024 Sep; 39(1):142. PubMed ID: 39289219
[TBL] [Abstract] [Full Text] [Related]
2. The value of FPR, FAR, CAR, CPR in the auxiliary diagnosis of colon cancer.
Zhao S; Ju Y; Gao B; Chu F; Lu B; Bao G; Ding S; Liu Y
Medicine (Baltimore); 2024 Aug; 103(31):e39133. PubMed ID: 39093732
[TBL] [Abstract] [Full Text] [Related]
3. Evaluating the role of wound-healing genes in conjunction with stool routine and serum tumor markers for colorectal cancer diagnosis and prognostic implications.
Yu K; Fang X
Int Wound J; 2024 Mar; 21(3):e14768. PubMed ID: 38446012
[TBL] [Abstract] [Full Text] [Related]
4. Serum Tumor Markers and Outcomes in Patients With Appendiceal Adenocarcinoma.
Yousef A; Yousef M; Zeineddine MA; More A; Fanaeian M; Chowdhury S; Knafl M; Edelkamp P; Ito I; Gu Y; Pattalachinti V; Naini ZA; Zeineddine FA; Peterson J; Alfaro K; Foo WC; Jin J; Bhutiani N; Higbie V; Scally CP; Kee B; Kopetz S; Goldstein D; Strach M; Williamson A; Aziz O; Barriuso J; Uppal A; White MG; Helmink B; Fournier KF; Raghav KP; Taggart MW; Overman MJ; Shen JP
JAMA Netw Open; 2024 Feb; 7(2):e240260. PubMed ID: 38416491
[TBL] [Abstract] [Full Text] [Related]
5. Histopathology and levels of proteins in plasma associate with survival after colorectal cancer diagnosis.
Magnusson MI; Agnarsson BA; Jonasson JG; Tryggvason T; Aeffner F; le Roux L; Magnusdottir DN; Gunnarsdottir HS; Alexíusdóttir KK; Gunnarsdottir K; Söebech E; Runarsdottir H; Jonsdottir EM; Kristinsdottir BS; Olafsson S; Knutsdottir H; Thorsteinsdottir U; Ulfarsson MO; Gudbjartsson DF; Saemundsdottir J; Magnusson OT; Norddahl GL; Watson JEV; Rafnar T; Lund SH; Stefansson K
Br J Cancer; 2023 Oct; 129(7):1142-1151. PubMed ID: 37596405
[TBL] [Abstract] [Full Text] [Related]
6. Early Screening of colorectal Precancerous Lesions Based on Combined Measurement of Multiple Serum Tumor Markers Using Artificial Neural Network Analysis.
Ke X; Liu W; Shen L; Zhang Y; Liu W; Wang C; Wang X
Biosensors (Basel); 2023 Jun; 13(7):. PubMed ID: 37504084
[TBL] [Abstract] [Full Text] [Related]
7. Correlation between Stool DNA-based SDC2 Methylation Tests Combined with Tumor Markers with Pathological Features in colorectal cancer.
Cheng Z; Wang Y; Wei W; Liu Y; Zhou Z
Clin Lab; 2023 Jul; 69(7):. PubMed ID: 37436377
[TBL] [Abstract] [Full Text] [Related]
8. Circulating extracellular vesicle-derived MARCKSL1 is a potential diagnostic non-invasive biomarker in metastatic colorectal cancer patients.
Rong W; Shao S; Pu Y; Ji Q; Zhu H
Sci Rep; 2023 Jun; 13(1):9957. PubMed ID: 37340044
[TBL] [Abstract] [Full Text] [Related]
9. Serum CA724 has no diagnostic value for gastrointestinal tumors.
Cao H; Zhu L; Li L; Wang W; Niu X
Clin Exp Med; 2023 Oct; 23(6):2433-2442. PubMed ID: 36920593
[TBL] [Abstract] [Full Text] [Related]
10. The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours.
Ain QU; Muhammad S; Hai Y; Peiling L
J Obstet Gynaecol; 2022 Nov; 42(8):3441-3449. PubMed ID: 36757337
[TBL] [Abstract] [Full Text] [Related]
11. Mean platelet volume/platelet count ratio in combination with tumor markers in colorectal cancer: a retrospective clinical study.
Zhang H; Lin F; Wang Z
BMC Cancer; 2023 Feb; 23(1):124. PubMed ID: 36750793
[TBL] [Abstract] [Full Text] [Related]
12. Clinical Value of PET.CT Based on Big Data in colorectal and Peritoneal Metastatic cancer.
Xiang L; Yang C; Liu W; Li D; Jiang Z; Zhou H
Contrast Media Mol Imaging; 2022; 2022():6120337. PubMed ID: 36262991
[TBL] [Abstract] [Full Text] [Related]
13. Methylated Septin9 has moderate diagnostic value in colorectal cancer detection in Chinese population: a multicenter study.
Lu DC; Zhang QF; Li L; Luo XK; Liang B; Lu YH; Hu BL; Jiang HX
BMC Gastroenterol; 2022 May; 22(1):232. PubMed ID: 35546391
[TBL] [Abstract] [Full Text] [Related]
14. The association of clinicopathological characterizations of colorectal cancer with membrane-bound mucins genes and LncRNAs.
Iranmanesh H; Entezari M; Rejali L; Nazemalhosseini-Mojarad E; Maghsoudloo M; Aghdaei HA; Zali MR; Hushmandi K; Rabiee N; Makvandi P; Ashrafizadeh M; Hashemi M
Pathol Res Pract; 2022 May; 233():153883. PubMed ID: 35452967
[TBL] [Abstract] [Full Text] [Related]
15. BH-index: A predictive system based on serum biomarkers and ensemble learning for early colorectal cancer diagnosis in mass screening.
Battista A; Battista RA; Battista F; Iovane G; Landi RE
Comput Methods Programs Biomed; 2021 Nov; 212():106494. PubMed ID: 34740064
[TBL] [Abstract] [Full Text] [Related]
16. Elevated N6-Methyladenosine RNA Levels in Peripheral Blood Immune Cells: A Novel Predictive Biomarker and Therapeutic Target for colorectal cancer.
Xie J; Huang Z; Jiang P; Wu R; Jiang H; Luo C; Hong H; Yin H
Front Immunol; 2021; 12():760747. PubMed ID: 34659267
[TBL] [Abstract] [Full Text] [Related]
17. Diagnostic value of combined detection of multiple tumor markers and blood lipid indexes in colorectal cancer and its prediction on adverse reactions of chemotherapy.
Jiang M; Ding G; Li G
J BUON; 2021; 26(4):1226-1230. PubMed ID: 34564974
[TBL] [Abstract] [Full Text] [Related]
18. Flexible diagnostic measures and new cut-point selection methods under multiple ordered classes.
Feng Y; Tian L
Pharm Stat; 2022 Jan; 21(1):220-240. PubMed ID: 34449107
[TBL] [Abstract] [Full Text] [Related]
19. Assessment of structural protein expression by FTIR and biochemical assays as biomarkers of metabolites response in gastric and colon cancer.
Guleken Z; Bulut H; Gültekin Gİ; Arıkan S; Yaylım İ; Hakan MT; Sönmez D; Tarhan N; Depciuch J
Talanta; 2021 Aug; 231():122353. PubMed ID: 33965021
[TBL] [Abstract] [Full Text] [Related]
20. Performance evaluation of CA242 by flow fluorescence assay.
Hou Y; Chen Y; Sun J; Geng J; Jin H; Zhang Z
Medicine (Baltimore); 2021 Apr; 100(15):e25301. PubMed ID: 33847629
[TBL] [Abstract] [Full Text] [Related]
[Next]
